CHANGPING YAO
Acupuncture at Grey Colt Ln, Gaithersburg, MD
License number
Maryland U001237
Category
Acupuncture
Type
Acupuncturist
Address
Address
11433 Grey Colt Ln, Gaithersburg, MD 20878
Phone
(240) 731-9068
Personal information
See more information about CHANGPING YAO at radaris.comName
Address
Phone
11433 Grey Colt Ln, North Potomac, MD 20878
Organization information
See more information about CHANGPING YAO at bizstanding.comChangping Yao
11433 Grey Colt Ln, Gaithersburg, MD 20878
Industry:
Business Services at Non-Commercial Site, Nonclassifiable Establishments
Research Scientist:
Changping Yao (Research Scientist)
Professional information
See more information about CHANGPING YAO at trustoria.com
Endothelial Monocyte Activation Polypeptide Ii, A Biomarker For Use In Diagnosis And Treatment Of Brain Injury
Endothelial Monocyte Activation Polypeptide Ii, A Biomarker For Use In Diagnosis And Treatment Of Brain Injury
US Patent:
2011002, Feb 3, 2011
Filed:
Aug 19, 2010
Appl. No.:
12/806725
Inventors:
Jitendra Ramanlal Dave - Gaithersburg MD, US
Changping Yao - Gaithersburg MD, US
Anthony Joseph Williams - Middletown MD, US
Xi-Chun May - Laurel MD, US
Frank Casper Tortella - Columbia MD, US
Ka-Wang Kevin Wang - Gainsville FL, US
Ronald Lawrence Hayes - Gainsville FL, US
Changping Yao - Gaithersburg MD, US
Anthony Joseph Williams - Middletown MD, US
Xi-Chun May - Laurel MD, US
Frank Casper Tortella - Columbia MD, US
Ka-Wang Kevin Wang - Gainsville FL, US
Ronald Lawrence Hayes - Gainsville FL, US
International Classification:
C40B 40/10, C40B 40/00
US Classification:
506 18, 506 13
Abstract:
A diagnostic tool and method of diagnosing brain injury and brain injury type (traumatic vs. ischemic) by detecting the level of expression of endothelial monocyte-activating polypeptide II (EMAP-II) and comparing to a control. An increase of EMAP-II indicates the presence of traumatic brain injury and a decrease of EMAP-II indicates the presence of ischemic brain injury. Detection of EMAP-II can be done in brain tissue, biofluids such as cerebrospinal fluid or blood (including plasma and serum)
Endothelial-Monocyte Activating Polypeptide Ii, A Biomarker For Use In Diagnosis And Treatment Of Brain Injury
Endothelial-Monocyte Activating Polypeptide Ii, A Biomarker For Use In Diagnosis And Treatment Of Brain Injury
US Patent:
2009006, Mar 12, 2009
Filed:
Oct 28, 2008
Appl. No.:
12/290174
Inventors:
Jitendra Ramanlal Dave - Gaithersburg MD, US
Changping Yao - Gaithersburg MD, US
Anthony Joseph Williams - Middletown MD, US
Xi-Chun May - Laurel MD, US
Frank Casper Tortella - Columbia MD, US
Ka-Wang Kevin Wang - Gainsville FL, US
Ronald Lawrence Hayes - Gainsville FL, US
Changping Yao - Gaithersburg MD, US
Anthony Joseph Williams - Middletown MD, US
Xi-Chun May - Laurel MD, US
Frank Casper Tortella - Columbia MD, US
Ka-Wang Kevin Wang - Gainsville FL, US
Ronald Lawrence Hayes - Gainsville FL, US
International Classification:
G01N 33/53, G01N 33/68, C12Q 1/02
US Classification:
435 792, 436 86, 435 29
Abstract:
A diagnostic tool and method of diagnosing brain injury and brain injury type (traumatic vs. ischemic) by detecting the level of expression of endothelial monocyte-activating polypeptide II (EMAP-II) and comparing to a control. An increase of EMAP-II indicates the presence of traumatic brain injury and a decrease of EMAP-II indicates the presence of ischemic brain injury. Detection of EMAP-II can be done in brain tissue, biofluids such as cerebrospinal fluid or blood (including plasma and serum)